gadolinium has been researched along with Amyloid Deposits in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Åslund, AKO; Bäck, M; Davies, CL; Hammarström, P; Nilsson, KPR; Nilsson, LNG; Sulheim, E; WiderØe, M | 1 |
| Allémann, E; Dumoulin, M; Forge, V; Heinrich-Balard, L; Lux, F; Marquette, C; Morfin, JF; Pansieri, J; Plissonneau, M; Rivory, P; Saraiva, MJ; Stransky-Heilkron, N; Tillement, O; Toth, E | 1 |
| Geraldes, CF; Martins, AF; Morfin, JF; Tóth, E | 1 |
| Agyare, EK; Curran, GL; Grant, SC; Jaruszewski, KM; Kandimalla, KK; Lowe, VJ; Paravastu, AK; Poduslo, JF; Ramakrishnan, S; Rosenberg, JT | 1 |
| Ballet, S; Borderies, H; Bort, G; Catoen, S; Ferroud, C; Kebsi, A; Louin, G; Port, M | 1 |
| Abakumova, TO; Chekhonin, VP; Gusev, EI; Nukolova, NV | 1 |
| Austen, B; Howe, F; Matharu, B; Spencer, N | 1 |
| Allémann, É; Cohen, R; Dumoulin, M; Forge, V; Heinrich-Balard, L; Louis, C; Lux, F; Marquette, C; Morfin, JF; Mowat, P; Pansieri, J; Plissonneau, M; Rivory, P; Saraiva, MJ; Stransky-Heilkron, N; Tillement, O; Tόth, É | 1 |
| Amatsubo, T; Morikawa, S; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
| Benavides, J; Bertrand, A; Debeir, T; Dhenain, M; Hantraye, P; Houitte, D; Petiet, A; Petit, F; Rooney, T; Santin, M; Wiggins, CJ | 1 |
| Hoang, DM; Sigurdsson, EM; Wadghiri, YZ; Wisniewski, T | 1 |
| Borowski, BJ; Curran, GL; Jack, CR; Macura, SI; Poduslo, JF; Sigurdsson, EM; Wengenack, TM; Wisniewski, T | 1 |
| Asuni, A; Blind, JA; de Leon, MJ; Knudsen, E; Li, Y; Mosconi, L; Sadowski, M; Scholtzova, H; Sigurdsson, EM; Tsui, WH; Turnbull, DH; Wadghiri, YZ; Wisniewski, T | 1 |
| Curran, GL; Gilles, EJ; Kandimalla, KK; Poduslo, JF; Wengenack, TM | 1 |
2 review(s) available for gadolinium and Amyloid Deposits
| Article | Year |
|---|---|
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Topics: Brain; Contrast Media; Demyelinating Diseases; Ferric Compounds; Gadolinium; Humans; Inflammation; Magnetic Resonance Imaging; Multiple Sclerosis; Nanoparticles; Plaque, Amyloid | 2015 |
Amyloid imaging using high-field magnetic resonance.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Tracking; Contrast Media; Fluorine Radioisotopes; Gadolinium; Humans; Magnetic Resonance Imaging; Plaque, Amyloid | 2010 |
12 other study(ies) available for gadolinium and Amyloid Deposits
| Article | Year |
|---|---|
Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Plaque, Amyloid | 2023 |
Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Diabetes Mellitus, Type 2; Gadolinium; Humans; Immunohistochemistry; Islet Amyloid Polypeptide; Mice; Multimodal Imaging; Nanoparticles; Plaque, Amyloid; Single-Domain Antibodies; Thiazoles | 2017 |
Gd(3+) complexes conjugated to Pittsburgh compound B: potential MRI markers of β-amyloid plaques.
Topics: Amyloid beta-Peptides; Aniline Compounds; Blood-Brain Barrier; Gadolinium; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Magnetic Resonance Imaging; Micelles; Organometallic Compounds; Peptide Fragments; Permeability; Plaque, Amyloid; Serum Albumin; Thiazoles; Water | 2014 |
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.
Topics: Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Line; Cerebral Amyloid Angiopathy; Cyclophosphamide; Drug Delivery Systems; Gadolinium; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Mice; Nanoparticles; Nanostructures; Plaque, Amyloid; Tomography, Emission-Computed, Single-Photon | 2014 |
Gadolinium-based contrast agents targeted to amyloid aggregates for the early diagnosis of Alzheimer's disease by MRI.
Topics: Alzheimer Disease; Animals; Contrast Media; Early Diagnosis; Gadolinium; Humans; Mice; Plaque, Amyloid; Radionuclide Imaging | 2014 |
Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biosensing Techniques; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Young Adult | 2015 |
Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Female; Gadolinium; Gene Expression; Hippocampus; Humans; Kinetics; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptides; Plaque, Amyloid; Prealbumin; Protein Binding; Surface Plasmon Resonance | 2016 |
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Topics: Alzheimer Disease; Animals; Brain; Contrast Media; Female; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Molecular Imaging; Plaque, Amyloid; Staining and Labeling; Tissue Distribution | 2012 |
In vivo magnetic resonance imaging of amyloid-β plaques in mice.
Topics: Amyloid beta-Peptides; Animals; Brain; Contrast Media; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mannitol; Mice; Mice, Transgenic; Plaque, Amyloid; Putrescine; Staining and Labeling | 2012 |
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzothiazoles; Binding, Competitive; Blood-Brain Barrier; Brain; Contrast Media; Disease Models, Animal; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Transgenic; Molecular Probe Techniques; Neurons; Peptide Fragments; Plaque, Amyloid; Predictive Value of Tests; Presenilin-1; Putrescine; Reproducibility of Results; Thiazoles | 2002 |
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Contrast Media; Disease Models, Animal; Gadolinium; Ligands; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Molecular Probe Techniques; Peptide Fragments; Plaque, Amyloid | 2008 |
Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebral Cortex; Contrast Media; Gadolinium; Hippocampus; Humans; Kinetics; Magnetic Resonance Imaging; Mice; Mice, Inbred Strains; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Presenilin-1 | 2007 |